These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33087787)

  • 1. Low E2F2 activity is associated with high genomic instability and PARPi resistance.
    Rennhack JP; Andrechek ER
    Sci Rep; 2020 Oct; 10(1):17948. PubMed ID: 33087787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells.
    Castillo DS; Campalans A; Belluscio LM; Carcagno AL; Radicella JP; Cánepa ET; Pregi N
    Cell Cycle; 2015; 14(8):1300-14. PubMed ID: 25892555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased metastasis with loss of E2F2 in Myc-driven tumors.
    Yuwanita I; Barnes D; Monterey MD; O'Reilly S; Andrechek ER
    Oncotarget; 2015 Nov; 6(35):38210-24. PubMed ID: 26474282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer.
    Hollern DP; Honeysett J; Cardiff RD; Andrechek ER
    Mol Cell Biol; 2014 Sep; 34(17):3229-43. PubMed ID: 24934442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury.
    Wu J; Sabirzhanov B; Stoica BA; Lipinski MM; Zhao Z; Zhao S; Ward N; Yang D; Faden AI
    Cell Cycle; 2015; 14(23):3698-712. PubMed ID: 26505089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
    Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
    Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of E2F2 in cancer progression and its value as a therapeutic target.
    Gao Y; Qiao X; Liu Z; Zhang W
    Front Immunol; 2024; 15():1397303. PubMed ID: 38807594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion.
    Bollig-Fischer A; Marchetti L; Mitrea C; Wu J; Kruger A; Manca V; Drăghici S
    Bioinformatics; 2014 Nov; 30(21):3036-43. PubMed ID: 25028721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZMIZ1 enhances ERα-dependent expression of E2F2 in breast cancer.
    Zhao W; Rose SF; Blake R; Godicelj A; Cullen AE; Stenning J; Beevors L; Gehrung M; Kumar S; Kishore K; Sawle A; Eldridge M; Giorgi FM; Bridge KS; Markowetz F; Holding AN
    J Mol Endocrinol; 2024 Jul; 73(1):. PubMed ID: 38564418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor compensation during mammary gland development in E2F knockout mice.
    To B; Andrechek ER
    PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
    González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
    Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
    Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution.
    Iglesias-Ara A; Zenarruzabeitia O; Buelta L; Merino J; Zubiaga AM
    Cell Death Differ; 2015 Oct; 22(10):1577-89. PubMed ID: 25656653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes.
    Liu L; Zhou W; Cheng CT; Ren X; Somlo G; Fong MY; Chin AR; Li H; Yu Y; Xu Y; O'Connor ST; O'Connor TR; Ann DK; Stark JM; Wang SE
    Mol Cancer Res; 2014 Nov; 12(11):1597-609. PubMed ID: 25103497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E2F transcription factor 2: What do we know?
    Li L; Wang S; Zhang Y; Pan J
    Biosci Trends; 2021 May; 15(2):83-92. PubMed ID: 33952804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting roles of E2F2 and E2F3 in cardiac neovascularization.
    Zhou J; Wu M; Xu S; Cheng M; Ding C; Liu Y; Yan H; Biyashev D; Kishore R; Qin G
    PLoS One; 2013; 8(6):e65755. PubMed ID: 23799044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
    Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15400-5. PubMed ID: 17881568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis.
    Zhou J; Cheng M; Wu M; Boriboun C; Jujo K; Xu S; Zhao TC; Tang YL; Kishore R; Qin G
    J Mol Cell Cardiol; 2013 Jul; 60():68-71. PubMed ID: 23603666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.